Migraine and Glaucoma: What a 3.6 Million-Person Meta-Analysis Found

Why This Matters

Glaucoma is a group of eye diseases that slowly damage the optic nerve, the cable that carries visual signals from the eye to the brain. It is a leading cause of irreversible blindness, and it usually causes no symptoms until a lot of vision has already been lost. Among adults aged 40 to 80, about 3.5% have it.

People with migraine already think a lot about their eyes. Visual aura, light sensitivity, and pain behind the eye are part of the condition for many. So a question comes up often in clinics and online: does migraine raise the risk of glaucoma?

Individual studies have disagreed. Some found a link, some found none, and a few found the opposite. A systematic review and meta-analysis published in Frontiers in Neurology in September 2026 pooled 19 of those studies to get a clearer answer.

How the Review Was Done

A team from Zhejiang Chinese Medical University searched PubMed, Embase, and the Cochrane Library up to April 2026, following PRISMA reporting standards with a protocol registered in advance on PROSPERO. Two reviewers screened studies independently, and study quality was scored with standard tools. Most included studies rated as high quality and none as low quality.

One Korean national cohort of more than 2.7 million people made up most of the total. In 13 studies a physician diagnosed migraine, and in 6 people reported it themselves. All 19 used statistical models to account for some other risk factors, although which factors varied a lot between studies.

What It Found

Across all 19 studies, people with migraine had about 28% higher odds of glaucoma than people without migraine. Removing studies one at a time did not change the result.

There were signs that small studies with weaker or negative findings may be missing from the published record. When the researchers statistically filled in about eight possibly missing studies, the estimate dropped to about 23% higher odds and stayed statistically significant. The authors suggest the 23% figure may be closer to the true size of the link.

The size of the link depended a great deal on how a study was run. The largest, most careful studies showed the smallest effects.

Reading the Numbers

What 23% to 28% higher odds looks like

Taking the review's starting figure of about 3.5 in 100 adults aged 40 to 80 with glaucoma, an odds ratio of 1.23 to 1.28 would put people with migraine at roughly 4.3 to 4.5 in 100. That is our rough illustration, not a figure from the study, and real risk depends on age, family history, ethnicity, eye pressure, and other factors.

Why the large studies matter most

The two strongest predictors of a big effect were self-reported migraine and clinic-based recruitment. People who already see an eye specialist or a headache specialist get examined more often, so glaucoma is more likely to be found in them. People who are worried about their health may also report headaches differently. The large database studies avoid some of these problems, and they consistently landed around 1.22.

What the review cannot sort out

• Cause and effect. Every included study was observational. A shared underlying factor could drive both conditions.
• Medications. The authors note that migraine drugs could muddy the picture. Triptans may affect blood flow to the eye, while beta-blockers such as propranolol (Inderal) might do the opposite. Most studies could not separate these effects.
• Subtypes. Most studies did not split migraine with and without aura, or open-angle and normal-tension glaucoma, so we cannot tell which combinations carry the link.
• Timing. Follow-up was generally too short to show how risk builds over decades.

Why the Two Might Be Linked

The authors describe several shared pathways. These are research ideas rather than established mechanisms.

The blood flow idea fits best with normal-tension glaucoma, where the optic nerve is damaged without high eye pressure. Several of the older studies in this review, mostly from North America, focused on low-tension or normal-tension glaucoma. If you want background on the CGRP molecule itself, our explainer on CGRP and the new migraine drugs covers how it works.

Protecting Your Eyes

Get a baseline eye exam

Because early glaucoma has no symptoms, the main protection is being checked. The American Academy of Ophthalmology recommends a baseline eye disease screening by age 40. If you have migraine plus other risk factors, such as a family history of glaucoma, ask whether you need one sooner or more often.

Tell your eye doctor about your migraine

Eye doctors look at the optic nerve, eye pressure, and visual field. Knowing you have migraine, and which medicines you take, helps them interpret those results. A one-page summary makes this easier, and our free migraine appointment summary sheet works for eye appointments too.

Know the topiramate warning

Separately from this review, topiramate (Topamax), a common migraine preventive, carries an FDA label warning for a rare reaction: sudden nearsightedness with angle-closure glaucoma. Symptoms include a sudden drop in vision or eye pain, usually within the first month of starting the drug. This is a medical emergency. Contact your doctor right away, since the usual treatment is stopping topiramate as quickly as possible.

Know when vision changes need checking

Typical visual aura builds over several minutes and fades within an hour. Our guide to aura characteristics describes the usual patterns. Vision loss that does not go away, a painful red eye, halos around lights with nausea, or a new pattern of visual symptoms should be checked promptly rather than put down to migraine.

Questions for Your Doctor

• Given my migraine and family history, when should I have my first full eye exam, and how often after that?
• Should my eye pressure and optic nerve be checked, or would a visual field test help?
• Do any of my migraine medications affect my eyes or eye pressure?
• If I start topiramate (Topamax), what eye symptoms should make me call right away?
• How can I tell my usual aura apart from a vision problem that needs urgent care?

If you are not sure whether your headaches are migraine in the first place, our 3-question migraine screening test is a starting point for that conversation.

Key Takeaways

The link between migraine and glaucoma is consistent but modest, and it is smallest in the largest studies. The review's authors call for prospective studies that separate migraine with and without aura and the different glaucoma types.